You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PCSK9 monoclonal antibody

Showing 1 - 25 of 8,813
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Homozygous Familial Hypercholesterolemia Trial in Beijing (IBI306)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • IBI306
  • Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Sep 12, 2022

Heterozygous Familial Hypercholesterolemia Trial in Beijing (Ongericimab, Placebo)

Recruiting
  • Heterozygous Familial Hypercholesterolemia
  • Ongericimab
  • Placebo
  • Beijing, Beijing, China
    Beijing Anzhen Hospital Capital Medical University City:Beijing
Apr 12, 2022

Advanced Cancer Trial in Zhengzhou (JS001(Toripalimab)+JS002)

Recruiting
  • Advanced Cancer
  • Zhengzhou, Henan, China
    Henan Tumor Hospital
Jan 10, 2022

Nephrotic Syndrome Trial in Dallas (Alirocumab, Alirocumab , Atorvastatin)

Terminated
  • Nephrotic Syndrome
  • Dallas, Texas
    DallasVAMC
Aug 17, 2022

Hypercholesterolemia Trial in Beijing (JS002, Placebo)

Completed
  • Hypercholesterolemia
  • Beijing, Beijing, China
    Fuwai Hospital Chinese Academy of Medical Sciences
Dec 11, 2019

Coronary Artery Disease, Atherosclerosis of Coronary Artery Trial in Nijmegen (Evolocumab 140 MG/ML [Repatha])

Recruiting
  • Coronary Artery Disease
  • Atherosclerosis of Coronary Artery
  • Evolocumab 140 MG/ML [Repatha]
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Jan 11, 2022

COVID-19 Trial in Joondalup (VYD222, Placebo)

Recruiting
  • COVID-19
  • Joondalup, Western Australia, Australia
    Linear Clinical Research
Apr 3, 2023

Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)

Recruiting
  • Non-Malignant Neoplasm
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial (Tafolecimab, Cholesterol Absorption Inhibitor,

Not yet recruiting
  • Acute Coronary Syndrome
  • Non ST Segment Elevation Acute Coronary Syndrome
  • (no location specified)
Oct 20, 2023

Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

Recruiting
  • Antibody-mediated Rejection
  • Vienna, Austria
  • +1 more
Aug 23, 2022

Hyperlipidemia Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +3 more
  • Birmingham, Alabama
  • +82 more
Nov 4, 2022

Colon Cancer, Pancreatic Cancer, Cholangiocarcinoma Trial run by the National Cancer Institute (NCI) (MVT-5873, pancreatectomy

Completed
  • Colon Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2022

Lyme Disease Trial in Lincoln (2217LS, 0.9% Sodium Chloride (NaCl))

Completed
  • Lyme Disease
  • 2217LS
  • 0.9% Sodium Chloride (NaCl)
  • Lincoln, Nebraska
    Celerion Inc.
Sep 15, 2022

Pancreatic Carcinoma, Tumors That Express CA 19-9 Trial in Scottsdale, New York (MVT-1075, MVT-5873)

Suspended
  • Pancreatic Carcinoma
  • Tumors That Express CA 19-9
  • Scottsdale, Arizona
  • +1 more
Aug 23, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Clear Cell Renal Cell Carcinoma Metastatic, TNBC - Triple-Negative Breast Cancer, Head Neck Cancer Trial (CA9hu-1)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma Metastatic
  • +4 more
  • (no location specified)
Jan 13, 2023

Hyperlipidemia Trial in Worldwide (Evolocumab, Ezetimibe, Placebo to Evolocumab)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +6 more
  • Birmingham, Alabama
  • +243 more
Nov 4, 2022

Plasmodium Falciparum Infection, Malaria Trial in Kisumu (L9LS, Normal Saline)

Recruiting
  • Plasmodium Falciparum Infection
  • Malaria
  • Kisumu, Kenya
    Kenya Medical Research Institute (KEMRI) Center for Global Healt
Sep 15, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +3 more
  • Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
  • VLP-encapsulated TLR9 Agonist CMP-001
  • Scottsdale, Arizona
  • +3 more
Jun 1, 2022

Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Jan 17, 2023

Axial Spondyloarthritis Trial in Saint Petersburg (anti-TRBV9 mAb, low dose, anti-TRBV9 mAb, high dose, )

Recruiting
  • Axial Spondyloarthritis
  • anti-TRBV9 monoclonal antibody, low dose
  • +2 more
  • Saint Petersburg, Russian Federation
  • +1 more
Jun 30, 2022

ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial (Evolocumab,

Not yet recruiting
  • ASCVD
  • +3 more
  • (no location specified)
Aug 3, 2023

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute

Recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 16, 2022

Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Relapsed Classical Hodgkin Lymphoma Trial in Stanford (Magrolimab, Pembrolizumab,

Recruiting
  • Hodgkin Lymphoma
  • +3 more
  • Stanford, California
    Stanford University
Jun 21, 2022

Coronary Vessel, Coronary Circulation, Atheroma; Myocardial Trial in Worldwide (Alirocumab)

Completed
  • Coronary Vessel
  • +2 more
  • Wien, Austria
  • +8 more
Feb 23, 2022